Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Accenture
McKinsey
Argus Health
Harvard Business School
AstraZeneca
Moodys
Fuji
UBS
Novartis

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075845

« Back to Dashboard

NDA 075845 describes OXAPROZIN, which is a drug marketed by Actavis Elizabeth, Amneal Pharms Co, Apotex Inc, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in thirteen NDAs. It is available from twenty suppliers. Additional details are available on the OXAPROZIN profile page.

The generic ingredient in OXAPROZIN is oxaprozin. There are thirteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the oxaprozin profile page.
Summary for 075845
Tradename:OXAPROZIN
Applicant:Sandoz
Ingredient:oxaprozin
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 075845
Suppliers and Packaging for NDA: 075845
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXAPROZIN oxaprozin TABLET;ORAL 075845 ANDA Eon Labs, Inc. 0185-0141 N 0185-0141-01
OXAPROZIN oxaprozin TABLET;ORAL 075845 ANDA Eon Labs, Inc. 0185-0141 N 0185-0141-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength600MG
Approval Date:Jan 31, 2001TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
Cerilliant
Dow
Citi
Queensland Health
Covington
Farmers Insurance
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot